Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

MA07.05 Psychosocial Needs and Programs of Cancer Patients/Survivors and Their Relatives: Unmet Needs From an International Study

Journal of Thoracic Oncology

English

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study From the BATTLE Trial

Journal of Thoracic Oncology

English

P1.04-21 the Utility of PD-L1/CD8 Dual Immunohistochemistry for Prediction of Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Characterization of 298 Patients With Lung Cancer Harboring MET Exon 14 Skipping Alterations

Journal of Thoracic Oncology

English

P3.cr-13 Dual Drive Coexistence of EML4-ALK Fusion and TPM3-ROS1 Fusion Lung Adenocarcinoma: A Case Report

Journal of Thoracic Oncology

English

P3.16-42 Early Stage Non-Small Cell Lung Cancer Survival in a Chilean Private Teaching Hospital

Journal of Thoracic Oncology

English

MA03.06 Descriptive Epidemiology of Significant Incidental Findings in a Large Clinical Lung Cancer Screening Program

Journal of Thoracic Oncology

English

Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation

Journal of Thoracic Oncology

English

ES02.02 PRO: To Medicate: Managing Breathlessness

Journal of Thoracic Oncology

English

Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

MA07.05 Psychosocial Needs and Programs of Cancer Patients/Survivors and Their Relatives: Unmet Needs From an International Study

Clinical and Biomarker Outcomes of the Phase II Vandetanib Study From the BATTLE Trial

P1.04-21 the Utility of PD-L1/CD8 Dual Immunohistochemistry for Prediction of Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)

Characterization of 298 Patients With Lung Cancer Harboring MET Exon 14 Skipping Alterations

P3.cr-13 Dual Drive Coexistence of EML4-ALK Fusion and TPM3-ROS1 Fusion Lung Adenocarcinoma: A Case Report

P3.16-42 Early Stage Non-Small Cell Lung Cancer Survival in a Chilean Private Teaching Hospital

MA03.06 Descriptive Epidemiology of Significant Incidental Findings in a Large Clinical Lung Cancer Screening Program

Brief Report: Pembrolizumab in Combination With Erlotinib or Gefitinib as First-Line Therapy for Advanced Non–Small-Cell Lung Cancer With Sensitizing EGFR Mutation

ES02.02 PRO: To Medicate: Managing Breathlessness

Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC